ACE2 and COVID-19: With the start of the COVID-19 pandemic, it was suggested that nAChRs might also be involved, although it was quickly shown that the main target for virus entry into the host cells is angiotensin-converting enzyme 2 (ACE2), which interacts with the receptor-binding domain (RBD) of the envelope Spike protein of the virus.